News from oncothyreon inc A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Sep 18, 2014, 08:45 ET

Oncothyreon Prices $40 Million Concurrent Public Offerings of Common Stock and Preferred Stock

SEATTLE, Sept. 18, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced the pricing of previously announced concurrent but separate...

Sep 17, 2014, 16:05 ET

Oncothyreon Announces Proposed Public Offerings

SEATTLE, WA, Sept. 17, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced that it intends to offer and sell shares of its Common...

Sep 02, 2014, 08:00 ET

Oncothyreon to Present at Rodman & Renshaw Global Investment Conference

SEATTLE, Sept. 2, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive...

Aug 11, 2014, 16:06 ET

Oncothyreon Reports Second Quarter 2014 Financial Results

Company to Hold Conference Call at 4:30 p.m. EDT Today SEATTLE, WA, Aug. 11, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today reported...

Aug 11, 2014, 16:02 ET

Oncothyreon Announces Acquisition of Alpine Biosciences

Oncothyreon to Leverage Alpine's Protocell Technology to Enable Targeted Delivery of Molecular Therapeutics for Serious Diseases Company to Hold...

Aug 04, 2014, 08:00 ET

Oncothyreon Announces Second Quarter 2014 Financial Results Conference Call

SEATTLE, Aug. 4, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Monday, August 11,...

Jun 02, 2014, 08:00 ET

Oncothyreon Announces Presentation of ONT-10 Data at ASCO Annual Meeting

SEATTLE, June 2, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced the presentation of data from a Phase 1 trial of ONT-10, an...

May 29, 2014, 08:00 ET

Oncothyreon and Celldex Therapeutics Announce Collaboration for Combination Immunotherapy Clinical Trial of ONT-10 and Varlilumab

SEATTLE, WA and HAMPTON, NJ, May 29, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) and Celldex Therapeutics, Inc., (NASDAQ: CLDX) today...

May 28, 2014, 16:03 ET

Oncothyreon to Present at Jefferies 2014 Global Healthcare Conference

SEATTLE, WA, May 28, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief Executive...

May 01, 2014, 16:05 ET

Oncothyreon Reports First Quarter 2014 Financial Results

Company to Hold Conference Call at 4:30 p.m. EDT Today SEATTLE, May 1, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today reported...

Apr 24, 2014, 08:00 ET

Oncothyreon Announces First Quarter 2014 Financial Results Conference Call

SEATTLE, April 24, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, May 1,...

Apr 07, 2014, 06:00 ET

Oncothyreon Announces Merck KGaA, Darmstadt, Germany, Initiation of Phase 3 START2 Study with Tecemotide in Stage III Non-Small Cell Lung Cancer

SEATTLE, April 7, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced that Merck KGaA, Darmstadt, Germany, has initiated the...

Mar 13, 2014, 16:01 ET

Oncothyreon Reports Full Year and Fourth Quarter 2013 Financial Results

Company to Hold Conference Call at 4:30 p.m. EDT Today SEATTLE, March 13, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today reported...

Mar 06, 2014, 08:00 ET

Oncothyreon Announces Full Year and Fourth Quarter 2013 Financial Results Conference Call

SEATTLE, March 6, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Thursday, March...

Feb 26, 2014, 08:00 ET

Oncothyreon to Present at Cowen and Company 34th Annual Health Care Conference

SEATTLE, WA, Feb. 26, 2014 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) announced today that Robert Kirkman, M.D., President and Chief...

Feb 20, 2014, 08:00 ET

Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with TDM-1 in Patients with Metastatic HER2+ Breast Cancer

SEATTLE, WA and BOULDER, CO, Feb. 20, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) and Array BioPharma Inc. (NASDAQ: ARRY) today announced...

Feb 03, 2014, 08:00 ET

Oncothyreon and Array BioPharma Announce Initiation of Phase 1b Trial of ONT-380 in Combination with Capecitabine and/or Trastuzumab in Patients with Metastatic HER2+ Breast Cancer

SEATTLE AND BOULDER, CO, Feb. 3, 2014 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) and Array BioPharma Inc. (NASDAQ: ARRY) today announced the...

Nov 12, 2013, 16:00 ET

Oncothyreon Reports Third Quarter 2013 Financial Results

Company to Hold Conference Call at 4:30 p.m. EST Today SEATTLE, WA, Nov. 12, 2013 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today reported...

Nov 08, 2013, 08:00 ET

Oncothyreon Announces Presentation of Data from Phase 1Trial of ONT-10

SEATTLE, Nov. 8, 2013 /PRNewswire/ - Oncothyreon Inc. (NASDAQ: ONTY) today announced the presentation of preliminary results from an ongoing...

Nov 04, 2013, 08:00 ET

Oncothyreon Announces Third Quarter 2013 Financial Results Conference Call

SEATTLE, Nov. 4, 2013 /PRNewswire/ - Oncothyreon Inc. (Nasdaq: ONTY) today announced that it will conduct a conference call on Tuesday, November...